摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-hydroxy-phenyl)-5-methyl-barbituric acid | 99985-16-7

中文名称
——
中文别名
——
英文名称
5-(4-hydroxy-phenyl)-5-methyl-barbituric acid
英文别名
5-(4-Hydroxy-phenyl)-5-methyl-barbitursaeure;5-(4-Hydroxy-phenyl)-5-methyl-pyrimidine-2,4,6-trione;5-(4-hydroxyphenyl)-5-methyl-1,3-diazinane-2,4,6-trione
5-(4-hydroxy-phenyl)-5-methyl-barbituric acid化学式
CAS
99985-16-7
化学式
C11H10N2O4
mdl
——
分子量
234.211
InChiKey
XTJZQNUILYKCRX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    95.5
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    2-(4-Benzyloxy-phenyl)-2-methyl-malonic acid dimethyl ester 在 palladium dihydroxide 氢气sodium methylate 作用下, 以 甲醇 为溶剂, 生成 5-(4-hydroxy-phenyl)-5-methyl-barbituric acid
    参考文献:
    名称:
    Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme
    摘要:
    New inhibitors of tumor necrosis factor-a converting enzyme (TACE) were discovered with a pyrimidine-2,4,6-trione in place of the commonly used hydroxamic acid. These non-hydroxamate TACE inhibitors were developed by incorporating a 4-(2methyl-4-quinolinylmethoxy)phenyl group, an optimized TACE selective P1' group. Several leads were identified with IC50 values around 100 nM in a porcine TACE assay and selective over MMP-1, -2, -9, -13, and aggrecanase. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.04.039
点击查看最新优质反应信息

文献信息

  • Ledvina et al., 1959, vol. 98, p. 840
    作者:Ledvina et al.
    DOI:——
    日期:——
  • Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme
    作者:James J.-W. Duan、Zhonghui Lu、Zelda R. Wasserman、Rui-Qin Liu、Maryanne B. Covington、Carl P. Decicco
    DOI:10.1016/j.bmcl.2005.04.039
    日期:2005.6
    New inhibitors of tumor necrosis factor-a converting enzyme (TACE) were discovered with a pyrimidine-2,4,6-trione in place of the commonly used hydroxamic acid. These non-hydroxamate TACE inhibitors were developed by incorporating a 4-(2methyl-4-quinolinylmethoxy)phenyl group, an optimized TACE selective P1' group. Several leads were identified with IC50 values around 100 nM in a porcine TACE assay and selective over MMP-1, -2, -9, -13, and aggrecanase. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多